Rand Paul failed to disclose for a year that his wife purchased stock in a company that makes a COVID-19 treatment.Kentucky Senator Rand Paul waited more than a year to disclose that his wife purchased stock in a company that makes a COVID-19 treatment, an investment made after Congress was briefed on the threat of the virus but before the public was largely aware of its danger.
The Republican filed a mandatory disclosure Wednesday revealing on Feb. 26, 2020 that Kelley Paul purchased somewhere between $1,001 and $15,000 worth of stock in Gilead, which makes the antiviral drug remdesivir. Under a 2012 law called the Stock Act, which was enacted to stop lawmakers from trading on insider information, any such sale should have been reported within 45 days.
...
The disclosure, made 16 months late, adds Paul to a growing list of lawmakers from both parties who have drawn scrutiny for their stock trading during the outbreak, which was declared a pandemic in March 2020.
In a statement, a Paul spokeswoman Kelsey Cooper said Kelley Paul used her own earnings to make the investment, which she lost money on. She said the failure by the senator, who is an eye surgeon, to disclose the trade was an oversight.
I'm tempted to move this from Safe R back to Likely R after this revelation.
